BioPerspectives

GEN BioPerspectives is a content forum where life science thought leaders share scientific insights or talk in their own words about issues that may enhance your research. This content is produced solely by GEN's marketing partners. More on Bioperspectives here, or email us at bioperspectives@genengnews.com.
Aug 20, 2008

First Tissue Culture System for Modeling HCV Infection

  • A University of California, San Diego School of Medicine researcher says she has developed the first tissue culture of normal, human liver cells that can model infection with the Hepatitis C virus (HCV) and provide a realistic environment to evaluate possible treatments. The novel cell line, described in the July 16 issue of PLoS ONE, might allow pharmaceutical companies to effectively test new drug candidates or possible vaccines for the HCV infection, which afflicts about 170 million people worldwide. Currently, there is no animal model that is effective for testing such therapies, according to the PLoS ONE paper.

    During this week's podcast, Dr. Martina Buck discusses the key components of her HCV infection model system and describes the unique aspects of her tissue culture system. She explains how her system differs from other cell cultures used to study HCV and further explores the paths pharmaceutical companies can follow to take advantage of her new cell line.

    Dr. Buck also talks about future plans to take her research project to the next stage.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.